Barclays Lowers Certara (NASDAQ:CERT) Price Target to $16.00

Certara (NASDAQ:CERT) had its target price cut by research analysts at Barclays from $18.00 to $16.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price points to a potential upside of 15.52% from the company’s current price.

CERT has been the subject of a number of other research reports. UBS Group upped their price objective on shares of Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a research report on Wednesday, April 10th. JMP Securities initiated coverage on shares of Certara in a research note on Thursday, April 4th. They issued a “market perform” rating for the company. Finally, Jefferies Financial Group upped their target price on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research note on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Certara currently has an average rating of “Hold” and an average price target of $19.81.

Certara Stock Performance

Shares of Certara stock opened at $13.85 on Friday. The firm has a fifty day moving average of $16.03 and a two-hundred day moving average of $16.88. The stock has a market capitalization of $2.23 billion, a price-to-earnings ratio of -35.51, a PEG ratio of 4.58 and a beta of 1.58. Certara has a 52 week low of $11.81 and a 52 week high of $19.87. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.26 and a current ratio of 3.26.

Certara (NASDAQ:CERT) last issued its earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $96.65 million for the quarter, compared to the consensus estimate of $94.48 million. Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. As a group, equities research analysts predict that Certara will post 0.29 EPS for the current year.

Insider Transactions at Certara

In related news, SVP Richard M. Traynor sold 3,000 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares in the company, valued at approximately $3,123,432. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Certara news, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now directly owns 173,524 shares in the company, valued at $3,123,432. The disclosure for this sale can be found here. Company insiders own 2.39% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CERT. Pineridge Advisors LLC bought a new position in shares of Certara during the fourth quarter worth approximately $28,000. Global Retirement Partners LLC increased its holdings in shares of Certara by 5,306.3% during the first quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock worth $31,000 after purchasing an additional 1,698 shares during the period. YHB Investment Advisors Inc. bought a new position in shares of Certara during the first quarter worth approximately $47,000. Natixis Advisors L.P. increased its holdings in shares of Certara by 13.4% during the third quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock worth $220,000 after purchasing an additional 1,791 shares during the period. Finally, Pacer Advisors Inc. boosted its position in shares of Certara by 1,704.0% during the 4th quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock worth $224,000 after acquiring an additional 12,047 shares in the last quarter. 73.96% of the stock is owned by institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.